Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > BioWorld Article

<< Previous

Bullboard Posts

Next >>

Post by Eoganachton Jul 12, 2023 2:10pm

427 Views

Post# 35537835

BioWorld Article

Light-activated compound possible answer to non-muscle invasive bladder cancer

July 10, 2023

By David Godkin

Theralase Technologies Inc. has pioneered technology said to selectively infiltrate and kill non-muscle invasive bladder cancer (NMIBC) at the cellular level. Bladder cancer generally is the 10th most common cancer in the world (6th in men and 17th in women), and gradually showing up in greater numbers in other patient groups.

That's all you get for free. If you want to read the whole article uou have to subscribe to BioWorld.

Subscriptions to BioWorld are $US 4,000.00 per year

If you want BioWorld Premium it's $US 9,000.00 per year

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China